Flexion Therapeutics Inc. | Key People and Executives
Michael D. Clayman
President, Chief Executive Officer & Director
Patrick J. Mahaffy
Chairman
Heath Lukatch
Independent Director
Mark P. Stejbach
Independent Director
Scott A. Canute
Independent Director
Sandesh Mahatme
Independent Director
C. Ann Merrifield
Independent Director
Alan W. Milinazzo
Independent Director
Sam D. Colella
Independent Director
Michael D. Clayman
President, Chief Executive Officer & Director
David A. Arkowitz
Chief Financial & Accounting Officer
Scott D. Kelley
Chief Medical Officer
Neil Bodick
Chief Scientific Officer
Dan Deardorf
Senior Vice President-Commercial
Carolyn Beaty Scimemi
Chief Compliance Officer
Dan Leblanc
Senior Vice President-CMC Operations
Adam L. Muzikant
Vice President-Business Development
Christina Willwerth
Senior Vice President-Program Management
Anna Diaz Triola
Vice President-Marketing
John Magee
Vice President-Sales
Scott Young
VP-Corporate Communications & Investor Relations
Mark S. Levine
Secretary, Senior VP & General Counsel
Kerry A. Wentworth
Chief Regulatory Officer
Patrick J. Mahaffy
Chairman
Heath Lukatch
Independent Director
Mark P. Stejbach
Independent Director
Scott A. Canute
Independent Director
Sandesh Mahatme
Independent Director
C. Ann Merrifield
Independent Director
Alan W. Milinazzo
Independent Director
Samuel D. Colella
Independent Director
| Address |
10 Mall Road
Burlington Massachusetts 01803
United States
|
|
Employees
|
- |
| Website |
http://www.flexiontherapeutics.com |
| Updated |
07/08/2019 |
| Flexion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. The firm specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. |
